Boston Scientific Corp (NYSE:BSX), purchasing 700,000 shares, making up 2.2% of the portfolio at a value of $58.66 million.
This adjustment increased the share count by 1.36% and had a 0.06% impact on the current portfolio, valuing at approximately ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback